MS
CELG

Marshall & Sullivan’s Celgene Corp CELG Stock Holding History

Marshall & Sullivan’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,219
Closed -$1.81M – 45
2019
Q1 		$1.81M Sell
19,219
-87
-0.5% -$7.61K 1.33% 29
2018
Q4 		$1.24M Sell
19,306
-1,135
-6% -$83.8K 1.08% 30
2018
Q3 		$1.83M Buy
20,441
+1,095
+6% +$96.8K 1.33% 27
2018
Q2 		$1.54M Buy
19,346
+1,388
+8% +$115K 1.42% 26
2018
Q1 		$1.6M Buy
17,958
+969
+6% +$93K 1.3% 27
2017
Q4 		$1.77M Buy
16,989
+421
+3% +$47.5K 1.42% 26
2017
Q3 		$1.67M Buy
16,568
+72
+0.4% +$9.81K 1.55% 26
2017
Q2 		$2.14M Buy
16,496
+60
+0.4% +$7.35K 1.85% 24
2017
Q1 		$1.96M Buy
16,436
+1,030
+7% +$123K 1.7% 26
2016
Q4 		$1.78M Sell
15,406
-123
-0.8% -$13.7K 2.17% 22
2016
Q3 		$1.62M Sell
15,529
-69
-0.4% -$7.47K 2.09% 23
2016
Q2 		$1.54M Sell
15,598
-64
-0.4% -$6.62K 1.98% 23
2016
Q1 		$1.57M Buy
15,662
+395
+3% +$40.7K 1.99% 25
2015
Q4 		$1.83M Sell
15,267
-155
-1% -$17.9K 2.42% 22
2015
Q3 		$1.73M Sell
15,422
-925
-6% -$115K 2.26% 24
2015
Q2 		$1.89M Buy
16,347
+54
+0.3% +$6.17K 2.55% 22
2015
Q1 		$1.88M Sell
16,293
-551
-3% -$65.8K 2.42% 21
2014
Q4 		$1.88M Sell
16,844
-2,586
-13% -$273K 2.34% 23
2014
Q3 		$1.84M Buy
19,430
+3,991
+26% +$360K 2.59% 22
2014
Q2 		$1.32M Sell
15,439
-341
-2% -$25.9K 2.21% 21
2014
Q1 		$1.1M Sell
15,780
-530
-3% -$42K 1.98% 25
2013
Q4 		$1.38M Sell
16,310
-304
-2% -$24.1K 2.53% 22
2013
Q3 		$1.28M Sell
16,614
-266
-2% -$18.6K 2.39% 23
2013
Q2 		$987K Buy
+16,880
New +$1.02M 2% 23

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Marshall & Sullivan's CELG Position: Q2 2019 in Review

Marshall & Sullivan sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 19,219 shares — an estimated $1.81M sold.

Marshall & Sullivan first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $2.14M in Q2 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Marshall & Sullivan reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Marshall & Sullivan sold 19,219 Celgene Corp shares in Q2 2019, an estimated $1.81M.
  • Marshall & Sullivan first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Marshall & Sullivan's Celgene Corp position peaked at $2.14M in Q2 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Marshall & Sullivan's 13F filing for Q2 2019, filed 5 Aug 2019.